Maurice Blackburn has lost a long-running fight with the Australian Taxation Office over a tax bill on two massive class action settlements secured by the firm for thousands of Black Saturday bushfire victims.
A serviced apartments provider has discontinued its appeal of a ruling that blocked it from trade marking the phrase “Waldorf Apartment”, after Hilton Worldwide — which owns New York’s iconic Waldorf Astoria hotel – opposed the move.
The Victorian Supreme Court has awarded a couple $145,000 in damages from a construction firm that denied them access to their brand new $5.8 million apartment and art gallery in Melbourne’s Eureka Tower for 130 weeks.
The ACCC has signed off on waste management company Bingo’s proposed $578 million acquisition of waste collection and processing service Dial-a-Dump, with the regulator saying Bingo’s proposal to divest a waste processing facility alleviated its competition concerns.
An appeal by federal Minister for Jobs Kelly O’Dwyer for review of a decision approving an enterprise agreement she clams unlawfully discriminates against female firefighters by restricting employees from working part time could, if successful, be revolutionary, the Fair Work Commission said Wednesday.
A litigation funder wants the High Court to review a court decision’s to approve a $64 million settlement in litigation over the failure of Banksia Securities while rejecting the funder’s commission and legal fees.
Danish pharmaceutical giant Lundbeck secured $51.7 million in settlements to end infringement litigation with three generic makers over its patent for the top-selling Lexapro, the company has revealed.
A state judge has ordered the litigation funders behind a group of federal class actions against AMP to pay the legal costs of their failed transfer applications, saying while he could not make the applicants pay, he could compel the funders to cough up the money.
Target Australia and Baby Bunting have agreed to pay penalties totalling $53,000 after being caught selling and marketing unsafe convertible strollers, the consumer watchdog said Wednesday.
Otsuka Pharmaceuticals and Bristol Myers-Squibb can retain their defences in an ongoing patent dispute over antipsychotic drug Abilify, after the Federal Court dismissed a strike out bid by the Commonwealth of Australia over the allegedly “inconsistent” pleadings.